Keyphrases
Visceral Leishmaniasis
100%
Human African Trypanosomiasis
90%
N-Myristoyltransferase Inhibitors
76%
Trypanosoma Brucei
74%
Trypanocidal Activity
60%
Antitrypanosomal Activity
57%
N-myristoyltransferase
50%
Central Nervous System
47%
Drug Target
44%
Naphthyridine
38%
Antimalarial Drugs
38%
Mefloquine
38%
Brain Penetrant
38%
Novel Leads
38%
Mouse Model
37%
In Vivo Efficacy
37%
Plasmodium Falciparum
34%
Amino
28%
Drug Discovery
28%
Dundee
28%
Fexinidazole
27%
T. Brucei
27%
Quinoline Methanol
25%
Brain Levels
23%
Mycobacterium Tuberculosis (M. tb)
23%
Metabolism
22%
Pharmacokinetics
22%
Mode of Action
21%
Mechanism of Action
20%
Lead Optimization
20%
Leishmania Donovani
19%
Inhibitor Identification
19%
Selective Antagonist
19%
Pyrimidine
19%
Antileishmanial Activity
19%
National Museums Scotland
19%
In Vivo Activity
19%
Skin Diseases
19%
Antitubercular Agents
19%
In Vivo Metabolites
19%
Psoriasis
19%
Targeted Inhibition
19%
U50,488
19%
Pyrazolo
19%
Opioid Agonist
19%
1,6-Naphthyridines
19%
Polyketide Synthase 13
19%
Preclinical Development
19%
PA-824
19%
Phosphoramidate
19%
Pharmacology, Toxicology and Pharmaceutical Science
Visceral Leishmaniasis
100%
African Trypanosomiasis
94%
Trypanosoma Brucei
60%
Pharmacokinetics
60%
Antimalarial Agent
57%
Structure Activity Relationship
48%
Plasmodium falciparum
47%
Drug Discovery
38%
Mefloquine
38%
Naphthyridine Derivative
38%
Fexinidazole
35%
Mouse Model
31%
Divalent
28%
Infection
25%
Methanol
25%
Prodrug
22%
Diseases
19%
Skin Disease
19%
Hexachlorophene
19%
Sulfonamide
19%
Psoriasis
19%
Drug Development
19%
G Protein Coupled Receptor
19%
Target Identification
19%
Cholinesterase Inhibitor
19%
Pyrazole
19%
Peroxisome Proliferator Activated Receptor
19%
Efficacy Study
19%
Plasmodium
19%
Antimalarial Activity
19%
Pyrimidine Derivative
19%
3,4 Dichloro N Methyl N [2 (1 Pyrrolidinyl)cyclohexyl]benzeneacetamide
19%
Opiate Agonist
19%
Aldo Keto Reductase
19%
Chelating Agent
19%
Trypanosomatidae
19%
Methylglyoxal
19%
Trypanosoma
19%
Antitrypanosomal
19%
Benznidazole
19%
Polyketide Synthase
19%
Prostaglandin
19%
Transition Element
19%
Isoprostane Derivative
19%
Proteome
19%
Leishmania donovani
18%
Prostaglandin F2
14%
Glyoxal
14%
Nitroreductase
13%
Antiproliferative Activity
12%